checkAd

    EANS-Adhoc  383  0 Kommentare LifeWatch schliesst im ersten Quartal 2012 insgesamt 41 zusätzliche Verträge für ACT und die Schlafanalyse zuhause ab (mit Dokument) - Seite 3


    objectives, and financial needs. These forward-looking statements are
    subject to a number of risks, uncertainties and assumptions. In light
    of these risks, uncertainties and assumptions, the forward-looking
    events and circumstances described may not occur and actual results
    could differ materially and adversely from those anticipated or
    implied in the forward-looking statements. All forward-looking
    statements are based only on data available to LifeWatch AG at the
    time of the issue of this press release. LifeWatch AG does not
    undertake any obligation to update any forward-looking statements
    contained in this press release as a result of new information,
    future events or otherwise.

    THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
    AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
    PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
    PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
    AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
    INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
    AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
    SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
    REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
    OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
    PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
    REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
    PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
    MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
    OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
    INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
    STATEMENTS OF THE ISSUER.

    Anhänge zur Meldung:
    ----------------------------------------------
    http://resources.euroadhoc.com/us/8MUZdXmA

    Rückfragehinweis:
    Sensus Investor & Public Relations, Zürich:

    Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-Mail lifewatch@sensus.ch

    Ende der Mitteilung euro adhoc
    --------------------------------------------------------------------------------

    Anhänge zur Meldung:

    ----------------------------------------------

    http://resources.euroadhoc.com/us/8MUZdXmA

    Emittent: LifeWatch AG
    Rundbuckstrasse 6
    CH-8212 Neuhausen am Rheinfall
    Telefon: +41 52 632 00 50
    FAX: +41 52 632 00 51
    Email: users@lifewatch.com
    WWW: www.lifewatch.com
    Branche: Gesundheitsdienste
    ISIN: CH0012815459
    Indizes: SPI, SPIEX
    Börsen: Freiverkehr: Berlin, Open Market (Freiverkehr) / XETRA: Frankfurt,
    Main Standard: SIX Swiss Exchange
    Sprache: Deutsch
    Seite 3 von 3




    news aktuell
    0 Follower
    Autor folgen

    Verfasst von news aktuell
    EANS-Adhoc LifeWatch schliesst im ersten Quartal 2012 insgesamt 41 zusätzliche Verträge für ACT und die Schlafanalyse zuhause ab (mit Dokument) - Seite 3 Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent …